UMVA has learned that a groundbreaking antibody therapy is delivering remarkable remission rates for patients battling aggressive head and neck cancers.




UMVA has learned that a groundbreaking antibody therapy is delivering remarkable remission rates for patients battling aggressive head and neck cancers.


